Your browser is no longer supported. Please, upgrade your browser.
Settings
CORT Corcept Therapeutics Incorporated daily Stock Chart
CORT [NASD]
Corcept Therapeutics Incorporated
Index- P/E19.85 EPS (ttm)0.60 Insider Own2.90% Shs Outstand114.82M Perf Week-2.87%
Market Cap1.36B Forward P/E10.09 EPS next Y1.17 Insider Trans-0.54% Shs Float103.49M Perf Month4.51%
Income75.40M PEG- EPS next Q0.19 Inst Own81.40% Short Float23.54% Perf Quarter-19.19%
Sales251.20M P/S5.41 EPS this Y-54.30% Inst Trans1.91% Short Ratio15.07 Perf Half Y-17.04%
Book/sh2.40 P/B4.93 EPS next Y38.49% ROA26.70% Target Price14.50 Perf Year-32.21%
Cash/sh1.80 P/C6.57 EPS next 5Y-11.90% ROE30.30% 52W Range9.14 - 20.00 Perf YTD-11.45%
Dividend- P/FCF11.77 EPS past 5Y26.90% ROI26.40% 52W High-40.85% Beta1.27
Dividend %- Quick Ratio6.50 Sales past 5Y89.20% Gross Margin97.90% 52W Low29.43% ATR0.47
Employees166 Current Ratio6.70 Sales Q/Q25.30% Oper. Margin35.60% RSI (14)40.80 Volatility3.18% 4.04%
OptionableYes Debt/Eq0.00 EPS Q/Q-82.90% Profit Margin30.00% Rel Volume0.43 Prev Close11.93
ShortableYes LT Debt/Eq0.00 EarningsFeb 25 AMC Payout0.00% Avg Volume1.62M Price11.83
Recom2.80 SMA20-2.85% SMA50-5.10% SMA200-13.67% Volume700,250 Change-0.84%
Feb-04-19Downgrade B. Riley FBR Buy → Neutral $22 → $12
Aug-10-18Reiterated Stifel Hold $20 → $11
May-31-18Downgrade Stifel Buy → Hold $20
Mar-09-18Initiated B. Riley FBR, Inc. Buy $30
Aug-31-17Initiated Stifel Buy $20
Feb-02-17Initiated Ladenburg Thalmann Buy $14
Apr-21-15Initiated FBR Capital Outperform $12
Jan-13-14Downgrade Stifel Buy → Hold
Aug-09-13Downgrade Ladenburg Thalmann Buy → Neutral $3.30
Aug-09-13Downgrade Janney Buy → Neutral
Feb-21-12Reiterated JMP Securities Mkt Outperform $9 → $11
Jan-06-10Upgrade Ladenburg Thalmann Neutral → Buy $4
Jul-17-08Initiated Rodman & Renshaw Mkt Outperform $8
Jun-21-07Upgrade Punk, Ziegel & Co Mkt Perform → Accumulate
Mar-21-19 05:30PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:48PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT PR Newswire
03:45PM  SHAREHOLDER ALERT: ASTE CORT UMC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:14PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated GlobeNewswire
10:50AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CORT, CAG, VNDA and INGN GlobeNewswire
Mar-20-19 09:57PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated Business Wire
08:41PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated CORT GlobeNewswire
05:01PM  CORCEPT THERAPEUTICS INCORPORATED INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Corcept Therapeutics Incorporated GlobeNewswire
04:05PM  Corcept Therapeutics Announces Poster Presentations at the 2019 Annual Meeting of the Endocrine Society Meeting GlobeNewswire
03:43PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm GlobeNewswire
09:55AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, BRS and AVP ACCESSWIRE
Mar-19-19 07:46PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated Business Wire
05:52PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
11:55AM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated Business Wire
10:35AM  CLASS ACTION UPDATE for ATVI, CORT and USX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:11AM  Bronstein, Gewirtz & Grossman, LLC Class Action Announcement: VALE, CORT & UMC ACCESSWIRE
09:30AM  CORT Class Action Alert: Hagens Berman Alerts Corcept Therapeutics (NASDAQ: CORT) Investors to Securities Class Action and May 13, 2019 Lead Plaintiff Deadline PR Newswire
08:00AM  Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces a Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated CORT GlobeNewswire
Mar-18-19 06:14PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
05:25PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CORT, VALE and BPI ACCESSWIRE
04:55PM  Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT PR Newswire
04:45PM  SHAREHOLDER ALERT: CORT INGN USX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:59PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Corcept Therapeutics Incorporated Investors Business Wire
03:00PM  Corcept Therapeutics Incorporated (CORT) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Deadline: May 13, 2019 GlobeNewswire
11:57AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, TYME, TAP and UMC GlobeNewswire
10:18AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT ACCESSWIRE
10:10AM  Bronstein, Gewirtz & Grossman, LLC Class Action Update: VALE, CORT & UMC ACCESSWIRE
08:30AM  Corcept Therapeutics Appoints Former Amgen Development Executive, Andreas Grauer, M.D., as Chief Medical Officer GlobeNewswire
Mar-17-19 11:00AM  CLASS ACTION UPDATE for ZIV, CORT, SVXY and BRS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Mar-15-19 11:48PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
08:00PM  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) GlobeNewswire
07:41PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PR Newswire
03:47PM  SHAREHOLDER ALERT: ZIV CORT GE WTW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
03:06PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ZIV, CORT, UXIN and GE GlobeNewswire
03:02PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm GlobeNewswire
01:43PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated CORT Business Wire
12:05PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MAXR, GSM and CORT ACCESSWIRE
11:10AM  Corcept Therapeutics Incorporated (CORT) Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ACCESSWIRE
Mar-14-19 07:30PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) and Encourages CORT Investors to Contact the Firm GlobeNewswire
05:05PM  Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of Corcept Therapeutics Incorporated Investors (CORT) Business Wire
Mar-11-19 02:54PM  Here's Why Corcept Therapeutics Shares Rose 11.5% in February Motley Fool
Mar-06-19 05:20PM  Short Squeeze on Corcept Therapeutics GuruFocus.com
Mar-01-19 08:52AM  What Should We Expect From Corcept Therapeutics Incorporateds (NASDAQ:CORT) Earnings In The Next Couple Of Years? Simply Wall St.
06:39AM  Edited Transcript of CORT earnings conference call or presentation 25-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-26-19 02:40PM  Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line Zacks
01:57PM  Corcept Therapeutics Incorporated (CORT) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-25-19 04:05PM  Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update GlobeNewswire
Feb-19-19 04:05PM  Corcept Therapeutics To Announce Audited Financial Results, Provide Corporate Update And Host Conference Call GlobeNewswire
Feb-11-19 08:31PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Corcept Therapeutics Incorporated Investors Business Wire
07:20AM  Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-08-19 08:50AM  Options Traders Expect Huge Moves in Corcept (CORT) Stock Zacks
Feb-07-19 04:13PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Corcept Therapeutics Incorporated Investors Business Wire
Feb-06-19 08:29AM  Investors Are Undervaluing Corcept Therapeutics Incorporated (NASDAQ:CORT) By 49.63% Simply Wall St. +5.27%
Feb-05-19 04:34PM  Investor Alert: Kaplan Fox Investigates Corcept Therapeutics Incorporated PR Newswire +7.94%
02:58PM  Puts Pop Amid Drug Stock's Roller-Coaster Session Schaeffer's Investment Research
Feb-01-19 12:17PM  Here's Why Corcept Therapeutics Fell as Much as 13.7% Today Motley Fool -10.29%
Jan-31-19 04:05PM  Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Preliminary Selected Financial Results; Provides 2019 Revenue Guidance GlobeNewswire
Jan-25-19 05:00PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Corcept Therapeutics Incorporated GlobeNewswire -11.01%
03:55PM  Here's Why Corcept Therapeutics Stock Fell as Much as 18.5% Today Motley Fool
02:17PM  Corcept Puts Active After Negative Report Schaeffer's Investment Research
Jan-11-19 01:15PM  Can Corcept Therapeutics Incorporated (NASDAQ:CORT) Maintain Its Strong Returns? Simply Wall St.
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-19-18 11:39PM  Is Corcept Therapeutics Incorporated (CORT) A Good Stock To Buy? Insider Monkey -8.78%
Dec-13-18 09:30AM  Biotech Companies in the News ACCESSWIRE
08:35AM  Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushings Syndrome GlobeNewswire
Dec-12-18 04:43PM  IBD 50 Stocks To Watch: Corcept Expected To Pick Up Growth In 2019 Investor's Business Daily
06:50AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Corcept Therapeutics ACCESSWIRE
Dec-11-18 04:58PM  Here's Why Corcept Therapeutics Surged Today Motley Fool +32.28%
04:26PM  Here's Why Corcept Therapeutics Rose 18.6% in November Motley Fool
Nov-30-18 08:15AM  Report: Exploring Fundamental Drivers Behind Tesla, Nordson, Paycom Software, PDL BioPharma, Corcept Therapeutics, and Willis Towers Watson Public New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-26-18 08:35AM  What You Must Know About Corcept Therapeutics Incorporateds (NASDAQ:CORT) Financial Strength Simply Wall St. +5.11%
Nov-20-18 04:24PM  Corcept Initiates Phase III Study for Cushing's Syndrome Zacks
Nov-19-18 09:05AM  Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushings Syndrome GlobeNewswire -7.14%
Nov-14-18 09:46PM  Edited Transcript of CORT earnings conference call or presentation 1-Nov-18 9:00pm GMT Thomson Reuters StreetEvents
Nov-05-18 02:25PM  Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates Zacks
Nov-01-18 08:15PM  Corcept Therapeutics (CORT) Meets Q3 Earnings Estimates Zacks
07:09PM  Corcept: 3Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Oct-31-18 02:52PM  Is Corcept Therapeutics Incorporateds (NASDAQ:CORT) CEO Incentives Align With Yours? Simply Wall St.
Oct-25-18 04:05PM  Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call GlobeNewswire
Oct-24-18 08:05AM  Judge Denies Teva Pharmaceuticals Motion to Dismiss Corcept Therapeutics Allegations of Patent Infringement GlobeNewswire -7.99%
Oct-23-18 09:00AM  Report: Exploring Fundamental Drivers Behind Corcept Therapeutics, News Corporation, Nightstar Therapeutics PLC Sponsored ADR, Rudolph Technologies, Applied Optoelectronics, and United Rentals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-04-18 10:08AM  Should You Be Holding Corcept Therapeutics Incorporated (NASDAQ:CORT) Right Now? Simply Wall St. -5.93%
Oct-01-18 07:15AM  Corcept Therapeutics Receives Orphan Designation for Relacorilant as Treatment for Pancreatic Cancer GlobeNewswire
Sep-12-18 08:52AM  Do Options Traders Know Something About Corcept (CORT) Stock We Don't? Zacks
Sep-04-18 08:03AM  Why These Fundamentals Make Corcept Therapeutics Incorporated (NASDAQ:CORT) Truly A Standout Investment Simply Wall St.
Aug-30-18 06:04PM  8 Stocks Joel Greenblatt Continues to Buy GuruFocus.com
Aug-29-18 07:35AM  Analysis: Positioning to Benefit within ShotSpotter, Frank's International N.V., Taseko Mines, Office Depot, Rudolph Technologies, and Corcept Therapeutics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +7.40%
Aug-26-18 11:55PM  Edited Transcript of CORT earnings conference call or presentation 9-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-25-18 06:01PM  Insider Buys Of The Week: Andeavor, Corcept, Portola Benzinga
Aug-24-18 07:30AM  [$$] Corcept Director Abruptly Switches to Buying Stock From Selling Barrons.com
Aug-20-18 04:57PM  3 High-Growth Stocks That Could Soar Motley Fool
Aug-10-18 12:38PM  Here's Why Corcept Therapeutics Inc. Fell as Much as 17.4% Today Motley Fool -5.15%
10:59AM  Corcept (CORT) Earnings and Revenues Miss Estimates in Q2 Zacks
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics ACCESSWIRE
07:38AM  The Daily Biotech Pulse: Puma, CareDx Soar On Earnings, Corcept Plunges On Bottom-Line Miss Benzinga
Aug-09-18 06:30PM  Corcept Therapeutics (CORT) Misses Q2 Earnings and Revenue Estimates Zacks
05:26PM  Corcept: 2Q Earnings Snapshot Associated Press
04:05PM  Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update GlobeNewswire
03:00PM  Corcept Therapeutics Incorporated. to Host Earnings Call ACCESSWIRE
Corcept Therapeutics Incorporated, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery, as well as develops CLIA-validated assay to measure FKBP5 gene expression. It is developing relacorilant that is in a Phase II trial to treat patients with Cushing's syndrome; abraxane in combination with relacorilant, which is in Phase I/II open label trial to treat solid tumors; and selective cortisol modulator CORT125281 combined with Xtandi that is in open label Phase I/II trial to treat patients with metastatic castration-resistant prostate cancer. The company is also developing CORT118335 selective cortisol modulator, which is in Phase I/II open label trial for the treatment of antipsychotic-induced weight gain and non-alcoholic steatotic hepatitis. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BELANOFF JOSEPH KChief Executive OfficerMar 20Option Exercise1.19782,885931,6332,947,080Mar 21 03:01 PM
WILSON JAMES NDirectorMar 07Option Exercise2.30105,782243,299115,782Mar 11 05:18 PM
Maduck SeanSee RemarksDec 13Option Exercise2.2410,00022,40030,024Dec 14 08:12 PM
Maduck SeanSee RemarksDec 12Option Exercise2.7860,000166,80680,024Dec 14 08:12 PM
BELANOFF JOSEPH KChief Executive OfficerDec 12Option Exercise1.19217,115258,3672,381,310Dec 14 07:50 PM
Robb Gary CharlesChief Financial OfficerDec 12Option Exercise1.9225,00048,00021,858Dec 14 07:51 PM
BELANOFF JOSEPH KChief Executive OfficerDec 12Sale19.01217,1154,126,5092,164,195Dec 14 07:50 PM
Maduck SeanSee RemarksDec 12Sale19.0160,0001,140,36620,024Dec 14 08:12 PM
Robb Gary CharlesChief Financial OfficerDec 12Sale19.0125,000475,1536,858Dec 14 07:51 PM
BAKER G LEONARD JRDirectorNov 21Buy12.7370,000890,7853,044,793Nov 26 05:13 PM
BAKER G LEONARD JRDirectorNov 21Buy12.7330,000381,765966,838Nov 26 05:13 PM
BAKER G LEONARD JRDirectorNov 13Buy12.8725,420327,1052,974,793Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 13Buy12.8710,895140,197936,838Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 12Buy12.9473,914956,6982,949,373Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 12Buy12.9431,677410,008925,943Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 09Buy13.0040,666528,6582,875,459Nov 14 05:26 PM
BAKER G LEONARD JRDirectorNov 09Buy13.0017,428226,564894,266Nov 14 05:26 PM
FISHMAN ROBERT SChief Medical OfficerNov 07Option Exercise3.518,00028,0808,000Nov 09 05:06 PM
FISHMAN ROBERT SChief Medical OfficerNov 07Sale13.748,000109,8870Nov 09 05:06 PM
FISHMAN ROBERT SChief Medical OfficerOct 08Option Exercise3.518,00028,0808,000Oct 09 05:11 PM
FISHMAN ROBERT SChief Medical OfficerOct 08Sale13.198,000105,5380Oct 09 05:11 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Option Exercise3.518,00028,0808,000Sep 11 04:36 PM
FISHMAN ROBERT SChief Medical OfficerSep 07Sale14.578,000116,5330Sep 11 04:36 PM
BAKER G LEONARD JRDirectorAug 20Buy12.9235,681461,0952,834,793Aug 22 05:54 PM
BAKER G LEONARD JRDirectorAug 17Buy12.805,79274,1172,799,112Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 16Buy12.49100,0001,248,7602,793,320Aug 20 06:19 PM
BAKER G LEONARD JRDirectorAug 15Buy12.4979,686994,9672,693,320Aug 16 05:51 PM
BAKER G LEONARD JRDirectorAug 14Buy12.47100,0001,247,000876,838Aug 16 05:51 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Option Exercise3.518,00028,0808,000Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerAug 07Sale14.158,000113,1850Aug 08 05:20 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Option Exercise3.518,00028,0808,000Jul 09 07:50 PM
FISHMAN ROBERT SChief Medical OfficerJul 06Sale15.098,000120,6860Jul 09 07:50 PM
WILSON JAMES NDirectorJun 29Option Exercise2.3010,00023,00010,000Jul 02 06:44 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Option Exercise3.518,00028,0808,000Jun 11 05:07 PM
FISHMAN ROBERT SChief Medical OfficerJun 07Sale18.238,000145,8260Jun 11 05:07 PM
Maduck SeanSee RemarksMay 15Option Exercise2.2410,00022,40020,024May 17 05:27 PM
BAKER G LEONARD JRDirectorMay 11Option Exercise2.2330,00066,900806,838May 15 05:30 PM
BAKER G LEONARD JRDirectorMay 11Sale16.0130,000480,312776,838May 15 05:30 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Option Exercise3.518,00028,0808,000May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerMay 07Sale17.688,000141,4280May 08 06:54 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Option Exercise3.518,00028,0808,000Apr 09 05:57 PM
FISHMAN ROBERT SChief Medical OfficerApr 06Sale16.228,000129,7840Apr 09 05:57 PM